A systematic review describes that the final histopathology diagnosis of GC was made in 87% of 169 prophylactic gastrectomies [12], supporting gastrectomy as the best recommendation in CDH1 mutation carrier individuals [8,9]. This evidence concerns the gene CDH1 and gastric cancer.